Artemisinin production using genetic and metabolomic engineering

RAKHMANOV, B.; IMAMKHODJAEVA, A.; UBAYDULLAEVA, Kh.; USMANOV, D.; MIRZAKHMEDOV, M.; SHERMATOV, Sh.; BURIEV, Z.

DSpace Home
→
Institutul de Microbiologie și Biotehnologie
→
Conferinţe
→
International scientific conference "Microbial Biotechnology"
→
2022
→
View Item

dc.contributor.author	RAKHMANOV, B.
dc.contributor.author	IMAMKHODJAEVA, A.
dc.contributor.author	UBAYDULLAEVA, Kh.
dc.contributor.author	USMANOV, D.
dc.contributor.author	MIRZAKHMEDOV, M.
dc.contributor.author	SHERMATOV, Sh.
dc.contributor.author	BURIEV, Z.
dc.date.accessioned	2024-02-09T09:44:12Z
dc.date.available	2024-02-09T09:44:12Z
dc.date.issued	2022
dc.identifier.citation	RAKHMANOV, B., IMAMKHODJAEVA, A., UBAYDULLAEVA, Kh. et al. Artemisinin production using genetic and metabolomic engineering. In: International Scientific Conference on Microbial Biotechnology, 5th edition, Chișinău, Moldova, October 12-13, 2022. Chişinău, 2022, p. 98. ISBN 978-9975-3555-6-8; ISBN 978-9975-3555-7-5.	en_US
dc.identifier.isbn	978-9975-3555-6-8
dc.identifier.isbn	978-9975-3555-7-5
dc.identifier.uri	https://doi.org/10.52757/imb22.66
dc.identifier.uri	http://repository.utm.md/handle/5014/26338
dc.description.abstract	Currently, artemisinin extract from Artemisia remains the main source for medicine, and its concentration in this plant is 0.01–1.2% in dry weight, but its content is relatively higher in cultivated varieties. Artemisinin is the most effective agent used in the fight against malaria in the world, as well as its promising properties are reported to combat against several types of cancer, viral diseases like hepatitis, inﬂuenza, human immunodeﬁciency virus (HIV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 (coronavirus disease 2019).	en_US
dc.language.iso	en	en_US
dc.publisher	Institute of Microbiology and Biotechnology, Republic of Moldova	en_US
dc.relation.ispartofseries	International scientific conference "Microbial Biotechnology", 5th edition, 12-13 October 2022, Chisinau, Republic of Moldova;
dc.rights	Attribution-NonCommercial-NoDerivs 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.subject	medicinal plants	en_US
dc.subject	Artemisia annua	en_US
dc.subject	Plasmodium falciparum	en_US
dc.subject	human diseases	en_US
dc.subject	therapy	en_US
dc.title	Artemisinin production using genetic and metabolomic engineering	en_US
dc.type	Article	en_US